The Irish government has finally begun a consultation on the development of the country’s first national biosimilars policy, with stakeholders being asked for their views on possible ways of stimulating the biosimilars market, such as switching, substitution, prescribing quotas and tenders.
Health minister Simon Harris said that an “evidence-based National Biosimilar Medicines Policy” would provide “clarity and certainty to...